Table 5.
Hyperkalemia treatment at the time of index hyperkalemia according to CKD stages
| Treatment | Hyperkalemia treatment on index date, n (%) |
|||||
|---|---|---|---|---|---|---|
| Stage 1 n = 170 | Stage 2 n = 1030 | Stage 3a n = 2464 | Stage 3b n = 3704 | Stage 4 n = 4139 | Stage 5 n = 2803 | |
| Thiazide diuretics | 0 (0.0) | 16 (1.6) | 65 (2.6) | 135 (3.6) | 152 (3.7) | 83 (3.0) |
| Loop diuretics | 12 (7.1) | 105 (10.2) | 399 (16.2) | 877 (23.7) | 1195 (29.9) | 699 (24.9) |
| Glucose injection+insulina | 1 (0.6) | 10 (1.0) | 14 (0.6) | 51 (1.4) | 104 (2.5) | 117 (4.2) |
| Calcium gluconate | 2 (1.2) | 5 (0.5) | 29 (1.2) | 45 (1.2) | 81 (2.0) | 103 (3.7) |
| Sodium bicarbonate | 0 (0.0) | 9 (0.9) | 15 (0.6) | 49 (1.3) | 136 (3.3) | 389 (13.9) |
| Potassium binder (SPS) | 1 (0.6) | 8 (0.8) | 21 (0.9) | 54 (1.5) | 115 (2.8) | 155 (5.5) |
| Potassium binder (CPS) | 8 (4.7) | 43 (4.2) | 83 (3.4) | 220 (5.9) | 437 (10.6) | 352 (12.6) |
CKD, chronic kidney disease; CPS, calcium polystyrene sulfonate; SPS, sodium polystyrene sulfonate.
a
Glucose injection + insulin was counted only when the glucose injection was used concomitantly with insulin on the same day.